The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Pathophysiology of Diabetes Mellitus in Cushing’s Syndrome
Abstract
Cushing’s syndrome is commonly complicated with an impairment of glucose metabolism, which is often clinically manifested as diabetes mellitus. The development of diabetes mellitus in Cushing’s syndrome is both a direct and indirect consequence of glucocorticoid excess. Indeed, glucocorticoid excess induces a stimulation of gluconeogenesis in the liver as well as an inhibition of insulin sensitivity both in the liver and in the skeletal muscles, which represent the most important sites responsible for glucose metabolism. In particular, glucocorticoid excess stimulates the expression of several key enzymes involved in the process of gluconeogenesis, with a consequent increase of glucose production, and induces an impairment of insulin sensitivity either directly by interfering with the insulin receptor signaling pathway or indirectly, through the stimulation of lipolysis and proteolysis and the consequent increase of fatty acids and amino acids, which contribute to the development of insulin resistance. Moreover, the peculiar distribution of adipose tissue throughout the body, with the predominance of visceral adipose tissue, significantly contributes to the worsening of insulin resistance and the development of a metabolic syndrome, which participates in the occurrence and maintenance of the impairment of glucose tolerance. Finally, glucocorticoid excess is able to impair insulin secretion as well as act at the level of the pancreatic beta cells, where it inhibits different steps of the insulin secretion process. This phenomenon is probably responsible for the passage from an impairment of glucose tolerance to an overt diabetes mellitus in susceptible patients with Cushing’s syndrome.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This is the case in both endogenous and medication-induced hypercortisolism (Cushing's syndrome), with up to 70% of patients developing impaired glycaemic control ( 4 ).”
From Dynamic modulation of glucose utilisation by glucocorticoid rhythms in health and disease (2020) · cites this paper as [4]
In the citing paper
“with chronic CORT excess (hypercortisolism) commonly associated with the impairment of glucose metabolism and the development of secondary type 2 diabetes ( 3, 4 ).”
From Dynamic modulation of glucose utilisation by glucocorticoid rhythms in health and disease (2020) · cites this paper as [4]
In the citing paper
“and by stimulating liver gluconeogenesis and glycogenolysis ( 4, 15 ).”
From Dynamic modulation of glucose utilisation by glucocorticoid rhythms in health and disease (2020) · cites this paper as [4]
Citations
Cites
Adipose Tissue as an Endocrine Organ
Kershaw, E. E., & Flier, J. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0395 · Cited by 5,522
Kahn, S. E. (2003) · Diabetologia · doi:10.1007/s00125-002-1009-0 · Cited by 2,166
Glucocorticoids and insulin resistance: old hormones, new targets
ANDREWS, R. C., & WALKER, B. R. (1999) · Clinical Science · doi:10.1042/cs0960513 · Cited by 731
RIZZA, R. A., MANDARINO, L. J., & GERICH, J. E. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-54-1-131 · Cited by 696 · cited 1×
“This action mainly reflects on a decrease of glycogen synthesis and glucose uptake. The direct interference of GCs with the insulin receptor signaling pathway has been demonstrated mostly in animal by in vitro and in vivo studies, which confirmed that GCs do not influence insulin receptor expression but mainly induce…”
BackgroundGlucocorticoids, metabolism and metabolic diseases
Vegiopoulos, A., & Herzig, S. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2007.05.015 · Cited by 535
Van Raalte, D. H., Ouwens, D. M., & Diamant, M. (2009) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2008.02067.x · Cited by 439
Effects of glucocorticoids on carbohydrate metabolism
Mcmahon, M., Gerich, J., & Rizza, R. (1988) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610040105 · Cited by 390
Saad, M. J., Folli, F., Kahn, J. A., & Kahn, C. R. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116803 · Cited by 349
Hormonal regulation of hepatic gluconeogenesis.
Kraus-Friedmann, N. (1984) · Physiological Reviews · doi:10.1152/physrev.1984.64.1.170 · Cited by 276
Ruzzin, J., Wagman, A. S., & Jensen, J. (2005) · Diabetologia · doi:10.1007/s00125-005-1886-0 · Cited by 243
Research works printed but not linked: 5
- 10.1042%2FCS19980388 · DOI
- 10.1210%2Fjc.77.5.1180 · DOI · Paper page
- 10.1007%2Fs00125-003-1190-9 · DOI · Paper page
- 10.1074%2Fjbc.272.48.30261 · DOI
- 10.1210%2Fjc.81.7.2621 · DOI
Cited by
Sorted by citations
Regulation of glucose homeostasis by glucocorticoids
Kuo, T., McQueen, A., Chen, T.-C., & Wang, J.-C. (2015) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4939-2895-8_5 · Cited by 723
Complications of Cushing's syndrome: state of the art
Pivonello, R., Isidori, A. M., Martino, M. C. D., Newell-Price, J. D. C., Biller, B. M. K., & Colao, A. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)00086-3 · Cited by 694
Self-citationThe Treatment of Cushing's Disease
Pivonello, R., Leo, M. D., Cozzolino, A., & Colao, A. A. L. (2015) · Endocrine Reviews · doi:10.1210/er.2013-1048 · Cited by 478
Self-citationHyperglycemia Associated With Pasireotide: Results From a Mechanistic Study in Healthy Volunteers
Henry, R. R., Ciaraldi, T. P., Armstrong, D. A., Burke, P., Ligueros‐Saylan, M., & Mudaliar, S. R. D. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1771 · Cited by 256
Metabolic functions of glucocorticoid receptor in skeletal muscle
Kuo, T., Harris, C. A., & Wang, J.-C. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.03.003 · Cited by 254
Systemic Glucocorticoid Therapy: a Review of its Metabolic and Cardiovascular Adverse Events
Fardet, L., & Fève, B. (2014) · Drugs · doi:10.1007/s40265-014-0282-9 · Cited by 249
Treating the Side Effects of Exogenous Glucocorticoids; Can We Separate the Good From the Bad ?
Pofi, R., Caratti, G., Ray, D. W., & Tomlinson, J. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad016 · Cited by 237
Cushing's syndrome: epidemiology and developments in disease management
Feelders, R., Sharma, S., & Nieman, L. (2015) · Clinical Epidemiology · doi:10.2147/clep.s44336 · Cited by 210
Coumarins as potential antidiabetic agents
Li, H., Yao, Y., & Li, L. (2017) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12774 · Cited by 207
Diabetes in Cushing syndrome: basic and clinical aspects
Mazziotti, G., Gazzaruso, C., & Giustina, A. (2011) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2011.09.001 · Cited by 193
Mori, M. A., Thomou, T., Boucher, J., Lee, K. Y., Lallukka, S., Kim, J. K., Torriani, M., Yki‐Järvinen, H., Grinspoon, S. K., Cypess, A. M., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci73468 · Cited by 189
The hypertension of Cushing's syndrome
Isidori, A. M., Graziadio, C., Paragliola, R. M., Cozzolino, A., Ambrogio, A. G., Colao, A., Corsello, S. M., & Pivonello, R. (2014) · Journal of Hypertension · doi:10.1097/hjh.0000000000000415 · Cited by 220
Self-citationDalmazi, G. D., Vicennati, V., Rinaldi, E., Morselli‐Labate, A. M., Giampalma, E., Mosconi, C., Pagotto, U., & Pasquali, R. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-1039 · Cited by 186
Neuropsychiatric disorders in Cushing's syndrome
Pivonello, R., Simeoli, C., Martino, M. D. D., Cozzolino, A., de Leo, M., Iacuaniello, D., Pivonello, C., Negri, M., Pellecchia, M. T., Iasevoli, F., et al. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00129 · Cited by 116
Self-citationCushing’s disease: the burden of illness
Pivonello, R., Martino, M. D. D., de Leo, M., Simeoli, C., & Colao, A. (2017) · Endocrine · doi:10.1007/s12020-016-0984-8 · Cited by 153
Self-citationGlucocorticoids and Type 2 Diabetes: From Physiology to Pathology
Di Dalmazi, G., Pagotto, U., Pasquali, R., & Vicennati, V. (2012) · Journal of Nutrition and Metabolism · doi:10.1155/2012/525093 · Cited by 168
Chen, L., Gnanaraj, C., Arulselvan, P., El-Seedi, H. R., & Teng, H. (2019) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2018.11.026 · Cited by 163
Colao, A., Block, C. E. M. D., Gaztambide, M. S., Kumar, S., Seufert, J., & Casanueva, F. F. (2013) · Pituitary · doi:10.1007/s11102-013-0483-3 · Cited by 152
Self-citationRaff, H., Sharma, S. T., & Nieman, L. K. (2014) · Comprehensive Physiology · doi:10.1002/cphy.c130035 · Cited by 141
Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management
Scaroni, C., Zilio, M., Foti, M., & Boscaro, M. (2017) · Endocrine Reviews · doi:10.1210/er.2016-1105 · Cited by 140
Androulakis, I. I., Kaltsas, G., Κόλλιας, Γ., Markou, Α., Gouli, A., Thomas, D. A., Alexandraki, K., Papamichael, C. M., Hadjidakis, D., & Piaditis, G. P. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-4064 · Cited by 135
Janssen, J. A. M. J. L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158178 · Cited by 155
Cushing's syndrome: Overview of clinical presentation, diagnostic tools and complications
Barbot, M., Zilio, M., & Scaroni, C. M. (2020) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2020.101380 · Cited by 126
Gray, N. E., Lam, L. N., Yang, K., Zhou, A. Y., Koliwad, S., & Wang, J.-C. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.294124 · Cited by 116
Chronic Stress and Diabetes Mellitus: Interwoven Pathologies
Sharma, V. K., & Singh, T. G. (2020) · Current Diabetes Reviews · doi:10.2174/1573399815666191111152248 · Cited by 116
Management of hyperglycemia associated with pasireotide (SOM230): Healthy volunteer study
Breitschaft, A., Hu, K., Reséndiz, K. H., Darstein, C., & Golor, G. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.12.011 · Cited by 113
Divergent Effects of Oxytocin Treatment of Obese Diabetic Mice on Adiposity and Diabetes
Altirriba, J., Poher, A.-L., Caillon, A., Arsenijevic, D., Veyrat‐Durebex, C., Lyautey, J., Dulloo, A. G., & Rohner‐Jeanrenaud, F. (2014) · Endocrinology · doi:10.1210/en.2014-1466 · Cited by 113
Comorbidities in Cushing’s disease
Sharma, S. T., Nieman, L. K., & Feelders, R. A. (2015) · Pituitary · doi:10.1007/s11102-015-0645-6 · Cited by 141
Qian, K., Zhong, S., Xie, K., Yu, D., Yang, R., & Gong, D. (2015) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2655 · Cited by 104
Endocrine causes of nonalcoholic fatty liver disease
Marino, L. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i39.11053 · Cited by 93
Approach to the Patient: Diagnosis of Cushing Syndrome
Savas, M., Mehta, S., Agrawal, N., van Rossum, E. F. C., & Feelders, R. A. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac492 · Cited by 91
Advances in the epidemiology, pathogenesis, and management of Cushing’s syndrome complications
Arnaldi, G., Mancini, T., Tirabassi, G., Trementino, L., & Boscaro, M. (2012) · Journal of Endocrinological Investigation · doi:10.1007/bf03345431 · Cited by 85
Is diabetes in Cushing’s syndrome only a consequence of hypercortisolism?
Giordano, C., Guarnotta, V., Pivonello, R., Amato, M. C., Simeoli, C., Ciresi, A., Cozzolino, A., & Colao, A. (2014) · European Journal of Endocrinology · doi:10.1530/eje-13-0754 · Cited by 79
Self-citationTarantino, G. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i40.6735 · Cited by 81
UPDATE ON THE CLINICOPATHOLOGY OF PITUITARY ADENOMAS
Lim, C. T., & Korbonits, M. (2018) · Endocrine Practice · doi:10.4158/ep-2018-0034 · Cited by 75
Diabetes Mellitus Secondary to Cushing’s Disease
Barbot, M., Ceccato, F., & Scaroni, C. M. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00284 · Cited by 80
Glucocorticoid‐induced osteoporosis: lessons from Cushing's syndrome
Tóth, M., & Grossman, A. (2013) · Clinical Endocrinology · doi:10.1111/cen.12189 · Cited by 81
Popoviciu, M. S., Păduraru, L., Nutas, R. M., Ujoc, A. M., Yahya, G., Metwally, K. A., & Cavalu, S. D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612676 · Cited by 93
Gragnoli, C. (2014) · The Application of Clinical Genetics · doi:10.2147/tacg.s39993 · Cited by 74
Influence of glucocorticoids and growth hormone on insulin sensitivity in humans
Yuen, K. C. J., Chong, L. E., & Riddle, M. (2013) · Diabetic Medicine · doi:10.1111/dme.12184 · Cited by 72
Molusky, M. M., Li, S., Ma, D., Yu, L., & Lin, J. D. (2012) · Diabetes · doi:10.2337/db11-0970 · Cited by 65
Arthritis and the role of endogenous glucocorticoids
Macfarlane, E., Seibel, M. J., & Zhou, H. (2020) · Bone Research · doi:10.1038/s41413-020-00112-2 · Cited by 64
Role of Glucocorticoids in Metabolic Dysfunction-Associated Steatotic Liver Disease
Pοlyzos, S. A., & Targher, G. (2024) · Current Obesity Reports · doi:10.1007/s13679-024-00556-1 · Cited by 71
Glucose metabolism in patients with subclinical Cushing’s syndrome
Giordano, R., Guaraldi, F., Berardelli, R., Karamouzis, I., D’Angelo, V., Marinazzo, E., Picu, A., Ghigo, E., & Arvat, E. (2012) · Endocrine · doi:10.1007/s12020-012-9628-9 · Cited by 64
Chen, L., Cao, H., & Xiao, J. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813572-3.00002-6 · Cited by 68
Dietary triterpenes in the treatment of type 2 diabetes: To date
Teng, H., Yuan, B., Gothai, S., Arulselvan, P., Song, X., & Chen, L. (2017) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2017.11.012 · Cited by 62
Management of hyperglycaemia in Cushing's disease: Experts’ proposals on the use of pasireotide
Reznik, Y., Bertherat, J. Y., Borson‐Chazot, F., Brue, T. C., Chanson, P., Cortet‐Rudelli, C., Delemer, B., Tabarin, A., Bisot-Locard, S., & Vergès, B. L. (2012) · Diabetes & Metabolism · doi:10.1016/j.diabet.2012.10.005 · Cited by 59
Liraglutide and sitagliptin counter beta- to alpha-cell transdifferentiation in diabetes
Tanday, N., Flatt, P. R., Irwin, N., & Moffett, R. C. (2020) · Journal of Endocrinology · doi:10.1530/joe-19-0451 · Cited by 56
Kahleová, H., McCann, J., Alwarith, J., Rembert, E., Tura, A., Holubkov, R., & Barnard, N. D. (2021) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2021.05.015 · Cited by 55
Dunford, E. C., & Riddell, M. C. (2016) · Metabolites · doi:10.3390/metabo6040044 · Cited by 55
Trementino, L., Appolloni, G., Concettoni, C., Cardinaletti, M., Boscaro, M., & Arnaldi, G. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-0722 · Cited by 53
Extended treatment of Cushing’s disease with pasireotide: results from a 2-year, Phase II study
Boscaro, M., Bertherat, J. Y., Findling, J. W., Fleseriu, M., Atkinson, A. B., Petersenn, S., Schopohl, J., Snyder, P. J., Hughes, G., Trovato, A., et al. (2013) · Pituitary · doi:10.1007/s11102-013-0503-3 · Cited by 50
Metabolic Alterations and Cardiovascular Outcomes of Cortisol Excess
Pivonello, R., Martino, M. C. D., Iacuaniello, D., Simeoli, C., Muscogiuri, G., Carlomagno, F., Leo, M. D., Cozzolino, A., & Colao, A. (2016) · Frontiers of hormone research · doi:10.1159/000443864 · Cited by 48
Self-citationPapanastasiou, L., Alexandraki, K., Androulakis, I. I., Fountoulakis, S., Kounadi, T., Markou, Α., Tsiavos, V., Samara, C., Papaioannou, T., Piaditis, G. P., et al. (2016) · Clinical Endocrinology · doi:10.1111/cen.13294 · Cited by 49
Koliwad, S. K., Gray, N. E., & Wang, J.-C. (2012) · Adipocyte · doi:10.4161/adip.20787 · Cited by 45
Glikokortykosteroidy a czynność komórek beta
Fichna, M., & Fichna, P. (2017) · Endokrynologia Polska · doi:10.5603/ep.2017.0060 · Cited by 43
Baroni, M. G., Giorgino, F., Pezzino, V., Scaroni, C., & Avogaro, A. (2016) · Journal of Endocrinological Investigation · doi:10.1007/s40618-015-0404-6 · Cited by 41
Hoekstra, M., van der Sluis, R. J., Eck, M. V., & van Berkel, T. J. C. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.300784 · Cited by 43
Cao, L., Mao, C., Li, S., Zhang, Y., Lv, J., Jiang, S., & Xu, Z. (2012) · Endocrinology · doi:10.1210/en.2012-1349 · Cited by 40
Melis, D., Rossi, A., Pivonello, R., Salerno, M., Balivo, F., Spadarella, S., Muscogiuri, G., Casa, R. D., Formisano, P., Andria, G., et al. (2015) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-015-0301-2 · Cited by 39
Self-citationLi, N., Yang, Z., Li, Q., Yu, Z., Chen, X., Li, J., Li, B., Ning, S., Cui, M., Sun, J., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0741-4 · Cited by 41
Vázquez, D. M., Neal, C. R., Patel, P. D., Kaciroti, N., & López, J. F. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.07.012 · Cited by 39
Glucose metabolism in Cushing's syndrome
Sharma, A. R., & Vella, A. V. (2020) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000537 · Cited by 41
Concurrent hyperadrenocorticism and diabetes mellitus in dogs
Miceli, D. D., Pignataro, O. P., & Castillo, V. A. (2017) · Research in Veterinary Science · doi:10.1016/j.rvsc.2017.07.026 · Cited by 36
Stress and the CRH System, Norepinephrine, Depression, and Type 2 Diabetes
Perrelli, M., Goparaju, P., Postolache, T., del Bosque-Plata, L., & Gragnoli, C. (2024) · Biomedicines · doi:10.3390/biomedicines12061187 · Cited by 33
Prevalence of Hypercortisolism in Difficult-to-Control Type 2 Diabetes
Buse, J. B., Kahn, S. E., Aroda, V. R., Auchus, R. J., Bailey, T. S., Bancos, I., Busch, R. S., Christofides, E. A., DeFronzo, R. A., Eilerman, B., et al. (2025) · Diabetes Care · doi:10.2337/dc24-2841 · Cited by 39
Ivović, M., Marina, L., Vujović, S., Tančić‐Gajić, M., Stojanovic, M. M., Radonjić, N. V., Gajić, M. M., Soldatović, I., & Micić, D. (2013) · Metabolism · doi:10.1016/j.metabol.2012.12.006 · Cited by 35
Glucocorticoids suppress GLP-1 secretion: possible contribution to their diabetogenic effects
Krizhanovskii, C., Fransson, L., Wolbert, P., & Ortsäter, H. (2015) · Clinical Science · doi:10.1042/cs20140719 · Cited by 35
Antidepressant-like effect of simvastatin in diabetic rats
ElBatsh, M. M. (2015) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2014-0560 · Cited by 34
Fein, H. G., Vaughan, T. B., Kushner, H., Cram, D., & Nguyen, D. (2015) · BMC Endocrine Disorders · doi:10.1186/s12902-015-0059-5 · Cited by 32
Rossi, A., Simeoli, C., Salerno, M., Ferrigno, R., Casa, R. D., Colao, A. A. L., Strisciuglio, P., Parenti, G., Pivonello, R., & Melis, D. (2020) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-020-01377-w · Cited by 32
Self-citationEncapsulation and immune protection for type 1 diabetes cell therapy
Kioulaphides, S., & Garcı́a, A. J. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115205 · Cited by 37
Hatipoglu, B. (2012) · Journal of Surgical Oncology · doi:10.1002/jso.23197 · Cited by 18
An Individualized Approach to the Evaluation of Cushing Syndrome
Sharma, S. T. (2017) · Endocrine Practice · doi:10.4158/ep161721.ra · Cited by 28
Pivonello, R., Elenkova, A. P., Fleseriu, M., Feelders, R. A., Witek, P., Greenman, Y., Geer, E. B., Perotti, P., Saiegh, L., Cohen, F. J., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.595894 · Cited by 31
Self-citationDeFronzo, R. A., Fonseca, V. A., Aroda, V. R., Auchus, R. J., Bailey, T. S., Bancos, I., Busch, R. S., Buse, J. B., Christofides, E. A., Eilerman, B., et al. (2025) · Diabetes Care · doi:10.2337/dc25-1055 · Cited by 29
Lonardo, A., & Weiskirchen, R. (2025) · Biomolecules · doi:10.3390/biom15121745 · Cited by 33
Sun, X., Feng, M., Lü, L., Zhao, Z., Bao, X., Deng, K., Yao, Y., Zhu, H., & Wang, R. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.600323 · Cited by 25
Wallia, A., Colleran, K., Purnell, J. Q., Gross, C., & Molitch, M. E. (2013) · Diabetes Care · doi:10.2337/dc13-0246 · Cited by 25
Secretory Phospholipase A2s in Insulin Resistance and Metabolism
Kuefner, M. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.732726 · Cited by 23
Active Cushing Disease Is Characterized by Increased Adipose Tissue Macrophage Presence
Lee, I. T., Opata, A. A., EĞRİTAĞ, H. E., Wang, L., Donovan, M. J., Buettner, C., & Geer, E. B. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02552 · Cited by 22
Cardiovascular Risks and Organ Damage in Secondary Hypertension
Cingolani, O. H. (2019) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2019.08.015 · Cited by 22
Dysregulation of Δ 4 -3-oxosteroid 5β-reductase in diabetic patients: Implications and mechanisms
Valanejad, L., Ghareeb, M., Shiffka, S. J., Nadolny, C., Chen, Y., Guo, L., Verma, R., You, S., Akhlaghi, F., & Deng, R. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.10.005 · Cited by 22
Nanomedicine in the Treatment of Diabetic Nephropathy
Desai, N., Koppisetti, H., Pande, S., Shukla, H., Sirsat, B., Ditani, A., Mallick, P. P., Kathar, U., Kalia, K., & Tekade, R. K. (2021) · Future Medicinal Chemistry · doi:10.4155/fmc-2020-0335 · Cited by 21
Transcriptional regulation of FoxO3 gene by glucocorticoids in murine myotubes
Kuo, T., Liu, P. H., Chen, T.-C., Lee, R. A., New, J., Zhang, D., Lei, C., Chau, A., Tang, Y., Cheung, E., et al. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00214.2015 · Cited by 20
Glucocorticoid-induced osteoporosis: 2013 update
Mazzantini, M., & Munno, O. D. (2014) · Reumatismo · doi:10.4081/reumatismo.2014.787 · Cited by 19
A Clinical Guide to Monogenic Diabetes
Carmody, D., Støy, J., Greeley, S. A. W., Bell, G. I., & Philipson, L. H. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800892-8.00002-6 · Cited by 18
Neonatal McCune‐Albright Syndrome: A Unique Syndromic Profile With an Unfavorable Outcome
Corsi, A., Cherman, N., DONALDSON, D. L., Robey, P. G., Collins, M. T., & Riminucci, M. (2018) · JBMR Plus · doi:10.1002/jbm4.10134 · Cited by 16
Busceti, C. L., Ferese, R., Bucci, D., Ryskalin, L., Gambardella, S., Madonna, M., Nicoletti, F., & Fornai, F. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20122901 · Cited by 16
Cushing’s Syndrome and Other Causes of Insulin Resistance in Dogs
Fleeman, L. M., & Barrett, R. (2023) · Veterinary Clinics of North America Small Animal Practice · doi:10.1016/j.cvsm.2023.01.009 · Cited by 15
Miceli, D. D., Vidal, P. N., Blatter, M. F. C., Pignataro, O. P., & Castillo, V. A. (2018) · Open Veterinary Journal · doi:10.4314/ovj.v8i2.13 · Cited by 15
Old Problem, New Concerns: Hypercortisolemia in the Time of COVID-19
Berlińska, A., Świątkowska−Stodulska, R., & Sworczak, K. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.711612 · Cited by 15
Canivell, S., Mohaupt, M. G., Ackermann, D., Pruijm, M. T., Guessous, I., Ehret, G., Escher, G., Péchère-Bertschi, A., Vogt, B., Devuyst, O., et al. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-017-0807-7 · Cited by 15
Lee, Y., Yi, H., Kim, H.-R., Joung, K. H., Kang, Y. E., Lee, J. H., Kim, K. S., Kim, H. J., Ku, B. J., & Shong, M. (2017) · Endocrinology and Metabolism · doi:10.3803/enm.2017.32.3.353 · Cited by 14
Baroni, M. G., Giorgino, F., PEZZINO, V., Scaroni, C. M., & Avogaro, A. (2016) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2016.02.001 · Cited by 14
Glucocorticoids Inhibit Basal and Hormone-Induced Serotonin Synthesis in Pancreatic Beta Cells
Ebou, M. H., Singh‐Estivalet, A., Launay, J., Callebert, J., Tronche, F., Ferré, P., Gautier, J., Guillemain, G., Bréant, B., Blondeau, B., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149343 · Cited by 15
Hendrickx, J. O., Moudt, S. D., Calus, E., Martinet, W., Guns, P., Roth, L., Deyn, P. P. D., Dam, D. V., & Meyer, G. R. Y. D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136656 · Cited by 13
Medical treatment of Cushing’s disease with concurrent diabetes mellitus
Mehlich, A., Bolanowski, M., Mehlich, D., & Witek, P. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1174119 · Cited by 13
The Effect of Curative Treatment on Hyperglycemia in Patients With Cushing Syndrome
Herndon, J. S., Kaur, R. J., Romportl, M., Smith, E., Koenigs, A., Partlow, B. J., Arteaga, L., & Bancos, I. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvab169 · Cited by 13
Wang, X., Magkos, F., Patterson, B. W., Reeds, D. N., Kampelman, J., & Mittendorfer, B. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0180 · Cited by 13
Metadata
- Authors
- Pivonello, R., De Leo, M., Vitale, P., Cozzolino, A., Simeoli, C., De Martino, M. C., Lombardi, G., & Colao, A.
- Affiliations
- Federico II University Hospital (IT)
- Venue
- Neuroendocrinology
- Publisher
- S. Karger AG
- Published
- 2010
- Volume
- 92
- Issue
- Suppl. 1
- Pages
- 77-81
- ISSN
- 0028-3835 (ISSN-L)
- 1423-0194
- OpenAlex
- W2100232797
- Cited by
- 190
- References
- 24
- Citations by year
- 2026: 6 · 2025: 10 · 2024: 14 · 2023: 13 · 2022: 8 · 2021: 15 · 2020: 14 · 2019: 13 · 2018: 13 · 2017: 11 · 2016: 10 · 2015: 17 · 2014: 13 · 2013: 16 · 2012: 14
- FWCI
- 7.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neuroendocrinology (publishedVersion)
- PubMed (publishedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- Cushing's syndrome, diabetes mellitus, glucocorticoid excess, insulin resistance, insulin secretion, gluconeogenesis, glucose tolerance, visceral adipose tissue, metabolic syndrome, pancreatic beta cells, lipolysis
- MeSH terms
- Insulin Secretion, Cushing Syndrome, Diabetes Mellitus, Glucose, Humans, Insulin, Insulin Resistance, Insulin-Secreting Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review